Lipid Profile in Tuberculosis Patients with and without Human Immunodeficiency Virus Infection

Table 2

(a) Baseline lipid profile levels (mg/dl) among HIV negative study groups (month 0)

Lipid name	HIV−TB+; ()	HIV−TST+; ()	HIV−TST−; ()	value
				HIV−TB+ versus HIV−TST+; value	HIV−TB+ versus HIV−TST−; value	HIV−TST+ versus HIV−TST−; value
TC	108 ( 87–130)	149 (140.5–162)	158 (150–192)	<0.001	<0.001	0.119
TG	75 (66–84)	83.5 (73–110.5)	119 (82–119)	0.027	<0.001	0.180
LDL	59.3 (46.9–73.2)	73.35 (63.8–87.2)	80.4 (73.5–105.1)	0.001	<0.001	0.072
HDL	26.5 (21.1–31.8)	42.4 (37.05–49.3)	44.7 (37.4–54.6)	<0.001	<0.001	0.276

Median (interquartile range) micronutrient level values are shown at baseline and significant differences between study groups were determined using Kruskal-Wallis H and Wilcoxon Mann–Whitney test.

(b) The proportional of the abnormality of lipid profile level among study groups at baseline

Lipid name	HIV+TB+; ()	HIV−TB+; ()	HIV+TST+; ()	HIV−TST+; ()	HIV−TST−; ()	value using Pearson Chi^2
TC < 130 mg/dl, N (%)	38 (86)	36 (73)	11 (65)	2 (8)	4 (4)	<0.001
TC ≥ 200 mg/dl, N (%)	0 (0)	0 (0)	0 (0)	1 (4)	6 (24)	<0.001
TG < 90 mg/dl, N (%)	30 (68)	40 (82)	13 (76)	14 (58)	8 (32)	0.001
TG ≥ 150 mg/dl, N (%)	0 (0)	0 (0)	0 (0)	2 (8)	2 (8)	0.056
LDL < 100 mg/dl, N (%)	43 (98)	46 (94)	15 (88)	19 (79)	17 (68)	0.002
LDL ≥ 130 mg/dl, N (%)	0 (0)	1 (2)	0 (0)	1 (4)	1 (4)	0.652
HDL < 40 mg/dl, N (%)	43 (98)	43 (88)	13 (76)	10 (42)	9 (36)	<0.001
HDL > 40 mg/dl, N (%)	1 (2)	6 (12)	4 (24)	14 (58)	16 (64)	0.000
TC < 130 & TG < 90 & LDL < 100 & HDL < 40	25 (40)	28 (44)	8 (13)	2 (3)	0 (0)